Related Experiment Video
Updated: Aug 15, 2026
An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
RSV: Management of the acute episode
1Department of Paediatrics and Child Health, University of Leeds, The General Infirmary at Leeds, D Floor, Clarendon Wing, Belmont Grove, Leeds, LS2 9NS, UK.
Insights
Bronchiolitis, a common infant respiratory infection, often requires hospitalization. Current infant bronchiolitis management relies on supportive care, with limited changes despite research into various treatments.
Area of Science:
- Pediatrics
- Infectious Diseases
- Respiratory Medicine
Background:
- Bronchiolitis is the leading cause of infant lower respiratory tract infections.
- It accounts for most pediatric hospital admissions during winter months.
- Current management remains largely supportive, focusing on oxygen and fluids.
Purpose of the Study:
- To review established and emerging treatment options for infant bronchiolitis.
- To discuss the efficacy and application of various therapeutic interventions.
- To explore recent advancements in intensive care and immunotherapy.
Main Methods:
- Literature review of current treatment options for bronchiolitis.
- Discussion of pharmacotherapies including bronchodilators, adrenaline, steroids, and ribavirin.
- Exploration of novel approaches like immunotherapy and intensive care.
Main Results:
- Established treatments like supplemental oxygen and fluid management remain central.
- Pharmacological interventions such as bronchodilators, adrenaline, steroids, and ribavirin have limited proven efficacy.
- Emerging strategies including immunotherapy and advanced intensive care are under investigation.
Conclusions:
- Despite numerous therapeutic options, management of infant bronchiolitis has seen minimal change.
- Supportive care remains the cornerstone of treatment.
- Further research is needed to establish effective targeted therapies for bronchiolitis.
Abstract:
Bronchiolitis is the most common lower respiratory tract infection in infants and is responsible for the majority of paediatric hospital admissions in the winter. Despite significant advances in pharmacotherapy, the management of infants with bronchiolitis has changed little over the years from supplemental oxygen and good fluid management. This paper reviews current treatment options for bronchiolitis, including the use of bronchodilators, adrenaline, steroids and ribavirin. More recent advances, including immunotherapy and intensive care, are discussed.
Related Concept Videos
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:29Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:21Rheumatic Heart Disease III: Medical Management
01:26Acute Coronary Syndrome V: Nursing Management
01:29Respiratory Syncytial Virus Disease